135
Views
0
CrossRef citations to date
0
Altmetric
Articles

Incidence of erectile dysfunction treatment after radical prostatectomy by Statin use in Finnish Nationwide Cohort Study

, ORCID Icon, &
Pages 53-59 | Received 19 Aug 2022, Accepted 10 Jan 2023, Published online: 23 Jan 2023

References

  • Najari BB, Kashanian JA. Erectile Dysfunction. JAMA. 2016;316(17):1838.
  • Kostis JB, Dobrzynski JM. Statins and erectile dysfunction. World J Mens Health. 2019;37(1):1–3.
  • Akbal C, Tinay I, Simşek F, et al. Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment. Int Urol Nephrol. 2008;40(2):355–363.
  • Imprialos KP, Stavropoulos K, Doumas M, et al. Sexual dysfunction, cardiovascular risk and effects of pharmacotherapy. Curr Vasc Pharmacol. 2018;16(2):130–142.
  • Kostis JB, Dobrzynski JM. The effect of statins on erectile dysfunction: a meta-analysis of randomized trials. J Sex Med. 2014;11(7):1626–1635.
  • Elgendy AY, Elgendy IY, Mahmoud AN, et al. Statin use in men and new onset of erectile dysfunction: a systematic review and meta-analysis. Am J Med. 2018;131(4):387–394.
  • Stamerra CA, Di Giosia P, Ferri C, et al. Statin therapy and sex hormones. Eur J Pharmacol. 2021;890:173745.
  • Loeb S, Bjurlin MA, Nicholson J, et al. Overdiagnosis and overtreatment of prostate cancer. Eur Urol. 2014;65(6):1046–1055.
  • Neal DE, Metcalfe C, Donovan JL, et al. Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received. Eur Urol. 2020;77(3):320–330.
  • Chung E, Gillman M. Prostate cancer survivorship: a review of erectile dysfunction and penile rehabilitation after prostate cancer therapy. Med J Aust. 2014;200(10):582–585.
  • Lima TFN, Bitran J, Frech FS, et al. Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities. Int J Impot Res. 2021;33(4):401–409.
  • Kontraros M, Varkarakis I, Ntoumas K, et al. Pathological characteristics, biochemical recurrence and functional outcome in radical prostatectomy patients on statin therapy. Urol Int. 2013;90(3):263–269.
  • Hong SK, Han BK, Jeong SJ, et al. Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy. J Urol. 2007;178(2):613–616.
  • Siltari A, Riikonen J, Fode M, et al. Effects of preoperative atorvastatin treatment on erectile function after radical prostatectomy: results from a subgroup of ESTO1, a randomized, double-blind, Placebo-Controlled study. J Sex Med. 2019;16(10):1597–1605.
  • Joentausta, Roni M., Rannikko, Antti, Murtola, Teemu J.,. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort. Prostate. 2019;79:583–591. Prostate. 2019;79(6):1420–1421.
  • ATC/DDD Index. 2021. [Internet]. Oslo, Norway: WHO Collaboration Centre for Drug statistics Methodology; [cited 2021 Aug 27]. Available from: https://www.whocc.no/atc_ddd_index/.
  • Osondu CU, Vo B, Oni ET, et al. The relationship of erectile dysfunction and subclinical cardiovascular disease: a systematic review and meta-analysis. Vasc Med. 2018;23(1):9–20.
  • Miner M, Parish SJ, Billups KL, et al. Erectile dysfunction and subclinical cardiovascular disease. Sex Med Rev. 2019;7(3):455–463.
  • Nurkalem Z, Yildirimtürk Ö, Özcan KS, et al. The effect of rosuvastatin and atorvastatin on erectile dysfunction in hypercholesterolaemic patients. Kardiol Pol. 2014;72(3):275–279.
  • Trivedi D, Kirby M, Wellsted DM, et al. Can simvastatin improve erectile function and health-related quality of life in men aged ≥40 years with erectile dysfunction? Results of the erectile dysfunction and statins trial [ISRCTN66772971. BJU Int. 2013;111(2):324–333.
  • Dadkhah F, Safarinejad MR, Asgari MA, et al. Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil. Int J Impot Res. 2010;22(1):51–60.
  • Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;2013(1):CD004816.
  • Koskinas KC, Siontis GCM, Piccolo R, et al. Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials. Eur Heart J. 2018;39(14):1172–1180.
  • Hatzimouratidis K. Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence. Clin Interv Aging. 2006;1(4):403–414.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.